Patents by Inventor Elliot Hahn

Elliot Hahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING POST-TRAUMATIC STRESS DISORDER
    Publication number: 20200197387
    Abstract: Disclosed and described is a novel dose titration procedure for administering the opioid antagonist, nalmefene, to a patient diagnosed with post-traumatic stress disorder (PTSD).
    Type: Application
    Filed: April 25, 2018
    Publication date: June 25, 2020
    Inventors: Hillel Glover, Elliot Hahn
  • ANTIVIRAL COMPOSITONS
    Publication number: 20120201883
    Abstract: A composition which includes a carboxamide, preferably ribavirin, for treating viral diseases in humans. A preferred embodiment of the subject invention comprises a very high dose (>600 mg) of ribavirin, and more preferably between about 800-1200 mg of ribavirin or more per dosage form.
    Type: Application
    Filed: December 9, 2010
    Publication date: August 9, 2012
    Applicant: ACCU-BREAK Technologies, Inc
    Inventors: Elliot Hahn, Robert I. Goldfarb, Lawrence Solomon, Allan S. Kaplan
  • PHARMACEUTICAL COMPOSITIONS HAVING NOVEL SCORING PATTERNS
    Publication number: 20080063709
    Abstract: The invention provides novel scoring patterns for a wide variety of tablets that contain specific drugs or contain drugs in certain drug classes, preferably doxepin.
    Type: Application
    Filed: September 21, 2007
    Publication date: March 13, 2008
    Inventors: Elliot Hahn, Lawrence Solomon
  • Controlled release formulation of captopril or a prodrug of captopril
    Patent number: 5728402
    Abstract: The invention provides a controlled release pharmaceutical unit dose composition for oral administration which comprises: (a) an internal phase which comprises captopril or a prodrug of captopril in admixture with a hydrogel forming agent; and (b) an external phase which comprises a coating which resists dissolution in the stomach.
    Type: Grant
    Filed: November 16, 1994
    Date of Patent: March 17, 1998
    Assignee: Andrx Pharmaceuticals Inc.
    Inventors: Chih-Ming Chen, Jane Chang Chen, Jainbo Xie, Elliot Hahn
  • Anti-viral compounds, dosage forms and methods
    Patent number: 5187163
    Abstract: Novel anti-viral compounds comprise phosphate-linked dimers of anti-viral nucleoside derivatives, or salts or esters of such nucleoside dimers. Pharmaceutical compositions containing the dimers and methods of treatment utilizing the same are disclosed.
    Type: Grant
    Filed: January 28, 1992
    Date of Patent: February 16, 1993
    Assignee: Baker Norton Pharmaceuticals, Inc.
    Inventors: Phillip Frost, Jack Fishman, Elliot Hahn, Jing J. Lu
  • Aldosterone biosynthesis inhibitor
    Patent number: 5120724
    Abstract: Aldosterone biosynthesis inhibitors having substantially no intrinsic antiandrogenic activity are disclosed as well as pharmaceutical compositions containing such compounds and methods of treatment utilizing these compositions.
    Type: Grant
    Filed: October 15, 1991
    Date of Patent: June 9, 1992
    Assignee: Baker Cummins Pharmaceuticals, Inc.
    Inventors: Jack Fishman, Elliot Hahn, Gregory A. Smith
  • Method of treatment for multiple sclerosis
    Patent number: 4994466
    Abstract: A method of treating a patient suffering from multiple sclerosis comprising daily administration to such patient of from about 1 to about 100 mg of a pure narcotic antagonist, e.g., nalmefene or naltrexone. The antagonist may be administered in divided doses from one to four times daily, preferably by the oral route. Parenteral, transmucosal and transdermal administration may be utilized where suitable.
    Type: Grant
    Filed: June 14, 1990
    Date of Patent: February 19, 1991
    Assignee: Baker Cummins Pharmaceuticals, Inc.
    Inventors: Fred P. Sherman, Elliot Hahn